Stock ORGC ORGANOCLICK AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings OrganoClick AB

Equities

ORGC

SE0006510335

Market Closed - Nasdaq Stockholm
Other stock markets
 11:00:05 2024-04-26 am EDT 		5-day change 1st Jan Change
3.2 SEK -0.93% Intraday chart for OrganoClick AB +1.59% +0.63%
Apr. 23 OrganoWood AB Announces Three-Year Results from the Field Study EN 12037 for Organowood Nowa CI
Apr. 19 OrganoClick CFO to Exit After Summer MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company sustains low margins.
  • The company appears highly valued given the size of its balance sheet.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
ORGANOCLICK AB Stock OrganoClick AB
+0.63% 28.59M
D+
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
A-
SIKA AG Stock Sika AG
-3.47% 46.34B
A-
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
B+
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
A-
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
C+
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
B+
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
A-
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
B+
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
  1. Stock Market
  2. Equities
  3. ORGC Stock
  4. Ratings OrganoClick AB